Perrigo Company Plc Receivables Turnover Ratio (PRGO), from the second quarter 2026 to the second quarter 2025 current and historic results, rankings and more - CSIMarket
CSIMarket
 


Perrigo Company Plc  (NYSE: PRGO)
 

Perrigo Plc Accounts Receivables Turnover Ratio from the second quarter 2026 to the second quarter 2025

Quarterly Results, Trends, Rankings, Statistics


Perrigo Company Plc's ability to collect accounts receivable sequentially worsen to 6.22, indicating more challenging environment then in the first quarter 2026, but still, it is a far cry from any concerns. Perrigo Plc's Accounts Receivable average collection period in the Jun 27 2026 quarter, has increased to 59 days, from 43 days, in the Mar 28 2026 quarter.

If we take a look into Healthcare sector 280 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 1466, from overall ranking in the first quarter 2026 at 2151.

What is Receivable Turnover Ratio?
What is Perrigo Company Plc Selling?


What is Receivable Turnover Ratio?





PRGO Receivables Turnover Ratio (Jun 27 2026)
II. Quarter
(Mar 28 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 27 2025)
III. Quarter
(Jun 28 2025)
II. Quarter
Y / Y Receivable Change 10821.54 % -2.75 % -4.59 % -18 % -99.1 %
Y / Y Revenue Change -3.17 % -7.17 % -2.52 % -4.07 % -0.79 %
Receivable Turnover Ratio (TTM) 6.22 8.52 8.59 8.52 8.04
PRGO's Total Ranking # 1466 # 2151 # 1587 # 1500 #
Accounts Receivable average collection period days 59 43 42 43 45
Seq. Receivable Change 1.84 % 13.76 % -4.9 % 9813.85 % -99.09 %
Seq. Revenue Change 5.61 % -12.72 % 6.38 % -1.25 % 1.25 %


Receivable Turnover Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 85
Healthcare Sector # 281
Overall Market # 1466

Receivable Turnover Ratio Statistics
High Average Low
8.59 5.43 4.21
(Dec 31 2025)   (Mar 28 2020)




  News about Perrigo Company Plc Receivables Turnover Ratios

Navigating Legal and Financial Quagmires The Case of Perrigo Company Plc Amidst Competitive Pressures

The pharmaceutical industry is characterized by rapid fluctuations in revenue and intense competition, often pitting companies against one another in the race for market dominance. The recent performance of Perrigo Company Plc (NYSE: PRGO) provides a case study in the complexities of maintaining profitability amid industry challenges. This article examines the company s declining revenues contrasted against its competitors, the legal ramifications from shareholder lawsuits, and the implications of its recent financial performance for stakeholders.Perrigo Company Plc, a notable player in the global healthcare sector, is currently facing scrutiny not only from its financial performance but also from class action lawsuits initiated by its shareholders. Most recently, The Gross Law Firm has issued notices to investors about a class action lawsuit against Perrigo, highlighting the mounting concern over the company’s fiscal health and corporate governance practices.




Financial Statements
Perrigo Plc's Accounts Receivable $ 710 Millions Visit PRGO's Balance sheet
Perrigo Plc's Sales TTM $ 4,144 Millions Visit PRGO's Income Statement
Sources of PRGO's Revenues Visit PRGO's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
PRGO's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
PRGO's Growth Rates PRGO's Roa PRGO's Inventory Turnover Ratio PRGO's Dividend Comparisons
PRGO's Profitability Ratios PRGO's Roi PRGO's Asset Turnover Ratio PRGO's Dividend Growth
PRGO's Valuation Ratios PRGO's Roe PRGO's Financial Strength Ratios PRGO's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Jun 27 2026, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Jun 27 2026 Receivable at quarter ending Jun 27 2026
Bioage Labs Inc   15.82 $ 10.355  Millions$ 0.655  Millions
Vaxart Inc   15.09 $ 243.064  Millions$ 16.108  Millions
Medicinova Inc   15.02 $ 0.920  Millions$ 0.061  Millions
Voyager Therapeutics Inc   14.71 $ 34.459  Millions$ 2.343  Millions
Halozyme Therapeutics Inc   14.68 $ 1,663.738  Millions$ 113.332  Millions
Nexgel Inc   14.52 $ 11.810  Millions$ 0.813  Millions
Skinhealth Systems Inc   14.42 $ 289.224  Millions$ 20.051  Millions
Lftd Partners Inc   14.13 $ 35.335  Millions$ 2.500  Millions
Talkspace Inc   14.09 $ 246.631  Millions$ 17.506  Millions
Lifestance Health Group Inc   14.07 $ 1,584.834  Millions$ 112.665  Millions
10x Genomics Inc   13.90 $ 616.566  Millions$ 44.342  Millions
Amneal Pharmaceuticals Inc   13.90 $ 3,117.474  Millions$ 224.342  Millions
Ataibeckley Inc   13.83 $ 4.473  Millions$ 0.324  Millions
Corcept Therapeutics Inc  13.54 $ 830.813  Millions$ 61.352  Millions
Rosecliff Acquisition Corp I  13.43 $ 16.467  Millions$ 1.226  Millions
Precipio inc   13.25 $ 27.198  Millions$ 2.052  Millions
Chemed Corporation  12.94 $ 2,595.001  Millions$ 200.565  Millions
Qhslab Inc   12.77 $ 3.017  Millions$ 0.236  Millions
Nrc Health  12.72 $ 139.996  Millions$ 11.004  Millions
Mannkind Corporation  12.39 $ 393.630  Millions$ 31.773  Millions
Petvivo Holdings Inc   12.34 $ 1.182  Millions$ 0.096  Millions
Siga Technologies Inc  12.32 $ 53.659  Millions$ 4.356  Millions
Alpha Pro Tech Ltd   12.25 $ 62.204  Millions$ 5.077  Millions
Vivos Therapeutics Inc   12.21 $ 21.135  Millions$ 1.731  Millions
Milestone Scientific Inc   11.98 $ 8.855  Millions$ 0.739  Millions
Teladoc Health Inc   11.88 $ 2,489.480  Millions$ 209.556  Millions
Premier Air Charter Holdings Inc   11.72 $ 31.562  Millions$ 2.692  Millions
Catheter Precision Inc   11.62 $ 1.915  Millions$ 0.165  Millions
Icu Medical Inc  11.42 $ 2,159.998  Millions$ 189.166  Millions
National Healthcare Corp  11.40 $ 1,559.020  Millions$ 136.723  Millions

Date modified: 2026-10-05T11:03:41+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.